证券代码：002258 股票简称：利尔化学 公告编号：2025-016 利尔化学股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准 确和完整，没有虚假记载、误导性陈述或重大遗漏。 一、特别提示 1、本次股东大会未出现否决议案的情况。 现场会议时间：2025 年 4 月 18 日（星期五）14:40 网络投票时间：2025 年 4 月 18 日 其中，通过深圳证券交易所（以下简称"深交所"）交易系统进行 网络投票的具体时间为 2025 年 4 月 18 日 9:15 至 9:25，9:30 至 11:30 和 13:00 至 15:00；通过深交所互联网投票系统投票的具体时 间为 2025 年 4 月 18 日 9:15 至 15:00 期间的任意时间。 （二）现场会议召开地点：公司绵阳园艺山办公区会议室（四川 省绵阳市涪城区园艺街 16 号久远创新产业园 1 号楼 7 楼会议室） （三）会议召开方式：现场会议和网络投票相结合 （四）会议召集人：公司董事会 （五）会议主持人：公司董事长尹英遂 2、本次股东大会不涉及变更以往股东大会已通过的决议的情况。 3、本次股东大 ...

泰和泰律师事务所 关于利尔化学股份有限公司 2024 年年度股东大会的 法律意见书 （2025）泰律意字（利尔化学）第 4 号 2025 年 4 月 18 日 中国 • 成都市天府新区正兴街道隆和西巷 299 号泰和泰中心 24—33F 24-33f, Tahota Center, No. 299 Longhe West Lane, Zhengxing Street, Tianfu New District, Chengdu, People's Republic of China 电话 | TEL：86-28-8662 5656 传真 | FAX：86-28-8525 6335 www.tahota.com 关于利尔化学股份有限公司 2024 年年度股东大会的法律意见书 泰和泰律师事务所 关于利尔化学股份有限公司 2024 年年度股东大会的法律意见书 (2025)泰律意字（利尔化学）第 4 号 致：利尔化学股份有限公司 泰和泰律师事务所（以下简称"本所"或"泰和泰"）接受利尔化学股份有 限公司（以下简称"公司"）的委托，根据《中华人民共和国公司法》（以下简 称"《公司法》"）、《中华人民共和国证券法》（以下简 ...

Core Viewpoint - Li Er Chemical's revenue and net profit are expected to decline in 2024 due to intense market competition and falling sales prices, but a significant recovery is anticipated in 2025 with a projected net profit increase of over 100% year-on-year [1] Group 1: Company Performance - In 2024, Li Er Chemical's operating income and net profit attributable to shareholders are expected to decrease by 6.87% and 64.34% respectively [1] - The company has established seven production bases across various regions in China, making it the largest producer of chloropyridine-based pesticide raw materials and formulations in the country [1] - Li Er Chemical's subsidiary, Li Er Biotechnology, achieved a net profit of 42.48 million yuan in 2024, demonstrating resilience in the competitive glyphosate market [2] Group 2: Market Trends - The price of glyphosate and its refined version has been on a downward trend, with domestic prices at 47,000 yuan/ton by the end of 2024, a decrease of 32.86% year-on-year [2] - Despite the price decline, market demand for glyphosate continues to grow, indicating potential for future development in this segment [2] - The company is optimistic about the future of glyphosate and refined glyphosate, although competition remains fierce [2] Group 3: Strategic Initiatives - Li Er Chemical plans to enhance its performance in 2025 by optimizing existing processes, improving product quality, and reducing production costs [3] - The company aims to strengthen cooperation with strategic customers and accelerate the registration and development of new products [3] - There is a focus on expanding international trade and marketing channels, as well as increasing effective R&D investment [3]

Financial Performance - Guang'an Lier's revenue for the previous year was 1.7 billion [2] - The increase in financial expenses for 2024 is primarily due to rising interest expenses [3] - The company's international sales revenue accounted for 47% of total revenue in 2024, with a portion exported to the United States [6][12] Business Operations - Core products contributing to revenue include glyphosate and propargyl fluoroacetamide, along with some intermediates [2] - The growth in pesticide intermediates and chemical materials business is driven by the completion of several base projects [3] - The company plans to enhance its product quality and reduce production costs to improve competitiveness [10] Market Outlook - The agricultural chemical industry is expected to undergo significant structural adjustments, with a focus on green development and stricter environmental regulations [5] - The global pesticide market is projected to grow steadily due to increasing food demand and the rapid development of genetically modified crops [5] - The company remains optimistic about the future of glyphosate despite current market competition [6] Strategic Initiatives - Future growth points include completing key projects on schedule, establishing international trade subsidiaries, and increasing R&D investment [4][10] - The company is actively monitoring the impact of increased tariffs on exports to the U.S. and is maintaining communication with clients [12] - Plans for potential acquisition of Shandong Huimeng are still in the planning stage, with funding expected to come from internal resources [8]

Core Insights - The report highlights a positive outlook for the rare earth industry, driven by a recovery in market conditions and increased sales profits, with a projected net profit for Guangsheng Nonferrous of 40 to 50 million yuan in Q1 2025, marking a significant turnaround from losses in the previous year [3] - The agricultural chemicals sector is also showing signs of recovery, with Limin Co. forecasting a net profit of 100 to 120 million yuan in Q1 2025, a substantial increase from a loss of 8.49 million yuan in the same period last year, attributed to rising product prices and a favorable market environment [3] - Tiande Yu expects a revenue increase of 60.52% year-on-year, with net profit reaching approximately 70.57 million yuan in Q1 2025, driven by the expansion of new products and markets, particularly in display driver chips and electronic price tag chips [4] Industry Analysis - The home appliance export sector faces significant challenges due to the recent implementation of a 10% minimum baseline tariff and additional tariffs that could raise the average tariff rate to around 80% for Chinese white goods exported to the U.S., creating a substantial impact on trade dynamics [6][7] - Companies with diversified production capacities and lower exposure to the U.S. market, such as TCL and Hisense, are better positioned to withstand tariff pressures due to localized production strategies [7] - Smaller enterprises that rely heavily on exports to the U.S. and lack overseas operations are likely to face severe cost pressures and may struggle to remain competitive, potentially leading to reduced orders and financial difficulties [8]

Investment Rating - The report maintains an "Outperform" rating for the company [5][36]. Core Insights - The global agricultural chemical inventory destocking is nearing its end, leading to a gradual stabilization in the company's revenue and profit levels [36][23]. - The company has experienced a significant decline in net profit due to the global agricultural chemical destocking cycle and rapid capacity expansion in the glyphosate industry, resulting in decreased prices for most pesticide products [36][32]. - The demand for refined glyphosate is rapidly growing, and the company is accelerating its overseas formulation registrations, which is expected to help restore profitability [48][2]. - The company has strengthened cooperation with major clients and plans to acquire a stake in Shandong Huimeng, which is expected to enhance its chlorinated pyridine and glyphosate business [3][55]. Summary by Sections Financial Performance - In 2024, the company achieved revenue of 7.311 billion yuan, a year-on-year decrease of 6.87%, and a net profit of 215 million yuan, down 64.34% year-on-year [36][4]. - The company expects a net profit of 1.45 to 1.55 billion yuan in the first quarter of 2025, representing a year-on-year increase of 203.08% to 223.98% [37][36]. - The company’s revenue and profit levels are expected to stabilize as the global agricultural chemical destocking cycle comes to an end [36][23]. Market Dynamics - The refined glyphosate market is experiencing rapid growth, with the company’s subsidiary achieving a net profit of 42.48 million yuan in 2024, demonstrating resilience in a challenging market [2][48]. - The company has completed registration for refined glyphosate formulations in eight countries, which is anticipated to support future profitability [48][2]. Strategic Initiatives - The company has established a joint venture with its largest client, achieving revenue of 566 million yuan and a net profit margin of 10.41%, higher than the company's overall margin [3][52]. - The planned acquisition of Shandong Huimeng is expected to create synergies in the chlorinated pyridine and glyphosate supply chains, enhancing the company's competitive position [55][3]. Future Projections - The company forecasts net profits of 402 million yuan, 519 million yuan, and 643 million yuan for 2025, 2026, and 2027, respectively, with corresponding EPS of 0.50, 0.65, and 0.80 yuan [5][4]. - The report anticipates a gradual recovery in the agricultural chemical market, with the company expected to benefit from improved operational efficiencies and market conditions [36][23].

利尔化学（002258）(002258.SZ)一季度业绩暴增。 近日，利尔化学发布一季度业绩预告，2025年1—3月，公司归母净利润预计为1.45亿元—1.55亿元，同 比增长203.08%—223.98%。 近两年农药行业景气度低迷，主营草铵膦产品的利尔化学业绩承压。今年一季度，公司部分产品的销量 和价格有所上涨，驱动经营业绩回暖。 同时长江商报记者注意到，利尔化学的存货改善，2024年存货周转天数下降。 二级市场上，业绩利好释放，截至4月7日收盘，利尔化学股价报9.78元/股，当日上涨9.64%。 一季度业绩大增 此外，随着2024年农药行业库存逐渐回归正常，利尔化学的库存周转天数也相比2023年有所改善，从 2023年的99.73天降低至97.19天。 回暖趋势延续至今年。4月2日晚间，利尔化学发布一季度业绩预告，2025年1—3月，公司归母净利润预 计为1.45亿元—1.55亿元，同比增长203.08%—223.98%；扣非净利润预计为1.43亿元—1.53亿元，同比 增长281.41%—308.09%。 对于一季度业绩增长，公司表示，部分产品的销量和价格有所上涨，导致一季度经营业绩同比实现增 长。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 一、股票交易异常波动的情况 利尔化学股份有限公司（以下简称"公司"、"本公司"、"利尔化学"）股票（证券简称：利尔化学；证券 代码：002258）于 2025年 4月7日连续1个交易日累计偏离超过 20%。根据《深圳证券交易所交易规 则》的相关规定，属于股票交易异常波动的情形。 二、股票交易异常波动的说明 针对公司股票交易异常波动，经向公司管理层、董事会、公司控股股东就相关问题进行了必要的核实， 公司说明如下： 1、公司前期披露的信息不存在需要重大补充、更正之处。 2、公司未发现近期公共传媒报道了可能或已经对本公司股票交易价格产生较大影响的未公开重大信 息。 3、公司近期生产经营情况正常，内外部经营环境未发生重大变化。公司已于 2025年4月4日在《中国证 券报》及巨潮资讯网（www.cninfo.com.cn）上披露了公司《2025年第一季度业绩预告》（公告编号： 2025-014），2025年第一季度，归属于上市公司股东的净利润比上年同期增长：203.08%- ...

Investment Rating - The report maintains an "Outperform" rating for the company [5][3]. Core Views - The global agricultural chemical destocking cycle is nearing its end, leading to a gradual stabilization in the company's revenue and profit levels. The company reported a revenue of 7.311 billion yuan in 2024, a decrease of 6.87% year-on-year, and a net profit of 215 million yuan, down 64.34% year-on-year. However, the company achieved a net profit of 83 million yuan in Q4 2024, marking a year-on-year increase of 89.94% and a quarter-on-quarter increase of 113.98% [1][31][32]. - The demand for refined glyphosate is rapidly growing, and the company is accelerating its overseas formulation registrations. The company has completed registrations in eight countries and reported a significant increase in exports of glyphosate derivatives [2][38]. - The company is deepening cooperation with major clients and plans to acquire equity in Shandong Huimeng, which is expected to enhance its chlorinated pyridine and glyphosate business [3][43]. Summary by Sections Financial Performance - In 2024, the company achieved a revenue of 73.11 billion yuan, a decrease of 6.87% year-on-year, and a net profit of 2.15 billion yuan, down 64.34% year-on-year. The basic earnings per share were 0.27 yuan. The gross profit margin was 16.06%, down 7.28 percentage points year-on-year, and the net profit margin was 4.08%, down 5.69 percentage points year-on-year [31][32]. - The company expects net profits for Q1 2025 to be between 145 million and 155 million yuan, representing a year-on-year increase of 203.08% to 223.98% [32]. Market Dynamics - The agricultural chemical industry is transitioning from a destocking phase to a period of overcapacity, with many agricultural products experiencing price declines. The company is positioned to benefit as the destocking cycle concludes [21][23]. - The refined glyphosate market is expanding, with the company’s subsidiary achieving a net profit of 42.48 million yuan in 2024, demonstrating resilience in a challenging market [2][38]. Strategic Initiatives - The company has established a joint venture with its largest client, achieving significant revenue and profit margins that exceed the company's overall performance [3][41]. - The planned acquisition of Shandong Huimeng is expected to create synergies in the chlorinated pyridine and glyphosate supply chains, enhancing the company's competitive position [43]. Future Outlook - The company forecasts a gradual recovery in profits, with expected net profits of 4.02 billion, 5.19 billion, and 6.43 billion yuan for 2025, 2026, and 2027, respectively [3][5].

证券代码：002258 股票简称：利尔化学 公告编号：2025-015 利尔化学股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露内容的真实、准 确和完整，没有虚假记载、误导性陈述或重大遗漏。 一、股票交易异常波动的情况 利尔化学股份有限公司（以下简称"公司"、"本公司"、"利尔化 学"）股票（证券简称：利尔化学；证券代码：002258）于 2025 年 4 月 7 日连续 1 个交易日累计偏离超过 20%。根据《深圳证券交易 所交易规则》的相关规定，属于股票交易异常波动的情形。 二、股票交易异常波动的说明 针对公司股票交易异常波动，经向公司管理层、董事会、公司控 股股东就相关问题进行了必要的核实，公司说明如下： 1、公司前期披露的信息不存在需要重大补充、更正之处。 2、公司未发现近期公共传媒报道了可能或已经对本公司股票交 易价格产生较大影响的未公开重大信息。 3、公司近期生产经营情况正常，内外部经营环境未发生重大变 化。公司已于 2025 年 4 月 4 日在《中国证券报》及巨潮资讯网 （www.cninfo.com.cn）上披露了公司《2025 年第一季度业绩预告》 （公告编号：202 ...